1
|
Knapp EM, Kaiser A, Arnold RC, Sampson MM, Ruppert M, Xu L, Anderson MI, Bonanno SL, Scholz H, Donlea JM, Krantz DE. Mutation of the Drosophila melanogaster serotonin transporter dSERT impacts sleep, courtship, and feeding behaviors. PLoS Genet 2022; 18:e1010289. [PMID: 36409783 PMCID: PMC9721485 DOI: 10.1371/journal.pgen.1010289] [Citation(s) in RCA: 12] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/09/2022] [Revised: 12/05/2022] [Accepted: 11/08/2022] [Indexed: 11/22/2022] Open
Abstract
The Serotonin Transporter (SERT) regulates extracellular serotonin levels and is the target of most current drugs used to treat depression. The mechanisms by which inhibition of SERT activity influences behavior are poorly understood. To address this question in the model organism Drosophila melanogaster, we developed new loss of function mutations in Drosophila SERT (dSERT). Previous studies in both flies and mammals have implicated serotonin as an important neuromodulator of sleep, and our newly generated dSERT mutants show an increase in total sleep and altered sleep architecture that is mimicked by feeding the SSRI citalopram. Differences in daytime versus nighttime sleep architecture as well as genetic rescue experiments unexpectedly suggest that distinct serotonergic circuits may modulate daytime versus nighttime sleep. dSERT mutants also show defects in copulation and food intake, akin to the clinical side effects of SSRIs and consistent with the pleomorphic influence of serotonin on the behavior of D. melanogaster. Starvation did not overcome the sleep drive in the mutants and in male dSERT mutants, the drive to mate also failed to overcome sleep drive. dSERT may be used to further explore the mechanisms by which serotonin regulates sleep and its interplay with other complex behaviors.
Collapse
Affiliation(s)
- Elizabeth M. Knapp
- Department of Psychiatry, University of California, Los Angeles, California, United States of America
| | - Andrea Kaiser
- Department of Biology, Institute of Zoology, Albertus-Magnus University of Cologne, Cologne, Germany
| | - Rebecca C. Arnold
- Department of Psychiatry, University of California, Los Angeles, California, United States of America
| | - Maureen M. Sampson
- Department of Psychiatry, University of California, Los Angeles, California, United States of America
| | - Manuela Ruppert
- Department of Biology, Institute of Zoology, Albertus-Magnus University of Cologne, Cologne, Germany
| | - Li Xu
- Department of Biology, Institute of Zoology, Albertus-Magnus University of Cologne, Cologne, Germany
| | | | - Shivan L. Bonanno
- Department of Psychiatry, University of California, Los Angeles, California, United States of America
| | - Henrike Scholz
- Department of Biology, Institute of Zoology, Albertus-Magnus University of Cologne, Cologne, Germany
| | - Jeffrey M. Donlea
- Department of Neurobiology, University of California, Los Angeles, California, United States of America
| | - David E. Krantz
- Department of Psychiatry, University of California, Los Angeles, California, United States of America
| |
Collapse
|
2
|
Zahra W, Birla H, Singh SS, Rathore AS, Dilnashin H, Singh R, Keshri PK, Gautam P, Singh SP. Neuroprotection by Mucuna pruriens in Neurodegenerative Diseases. Neurochem Res 2022; 47:1816-1829. [PMID: 35380400 DOI: 10.1007/s11064-022-03591-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/31/2021] [Revised: 03/22/2022] [Accepted: 03/24/2022] [Indexed: 10/18/2022]
Abstract
The medicinal plant Mucuna pruriens (Fabaceae) is widely known for its anti-oxidative and anti-inflammatory properties. It is a well-established drug in Ayurveda and has been widely used for the treatment of neurological disorders and male infertility for ages. The seeds of the plant have potent medicinal value and its extract has been tested in different models of neurodegenerative diseases, especially Parkinson's disease (PD). Apart from PD, Mucuna pruriens is now being studied in models of other nervous systems disorders such as Alzheimer's disease (AD), Amyotrophic lateral sclerosis (ALS) and stroke because of its neuroprotective importance. This review briefly discusses the pathogenesis of PD, AD, ALS and stroke. It aims to summarize the medicinal importance of Mucuna pruriens in treatment of these diseases, and put forward the potential targets where Mucuna pruriens can act for therapeutic interventions. In this review, the effect of Mucuna pruriens on ameliorating the neurodegeneration evident in PD, AD, ALS and stroke is briefly discussed. The potential targets for neuroprotection by the plant are delineated, which can be studied further to validate the hypothesis regarding the use of Mucuna pruriens for the treatment of these diseases.
Collapse
Affiliation(s)
- Walia Zahra
- Department of Biochemistry, Institute of Science, Banaras Hindu University, Varanasi, 221005, India
| | - Hareram Birla
- Department of Biochemistry, Institute of Science, Banaras Hindu University, Varanasi, 221005, India
| | - Saumitra Sen Singh
- Department of Biochemistry, Institute of Science, Banaras Hindu University, Varanasi, 221005, India
| | - Aaina Singh Rathore
- Department of Biochemistry, Institute of Science, Banaras Hindu University, Varanasi, 221005, India
| | - Hagera Dilnashin
- Department of Biochemistry, Institute of Science, Banaras Hindu University, Varanasi, 221005, India
| | - Richa Singh
- Department of Biochemistry, Institute of Science, Banaras Hindu University, Varanasi, 221005, India
| | - Priyanka Kumari Keshri
- Department of Biochemistry, Institute of Science, Banaras Hindu University, Varanasi, 221005, India
| | - Priyanka Gautam
- Department of Neurology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, 221005, India
| | - Surya Pratap Singh
- Department of Biochemistry, Institute of Science, Banaras Hindu University, Varanasi, 221005, India.
| |
Collapse
|
3
|
Antinori ME, Contardi M, Suarato G, Armirotti A, Bertorelli R, Mancini G, Debellis D, Athanassiou A. Advanced mycelium materials as potential self-growing biomedical scaffolds. Sci Rep 2021; 11:12630. [PMID: 34135362 PMCID: PMC8209158 DOI: 10.1038/s41598-021-91572-x] [Citation(s) in RCA: 23] [Impact Index Per Article: 7.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/22/2021] [Accepted: 05/17/2021] [Indexed: 12/11/2022] Open
Abstract
Mycelia, the vegetative part of fungi, are emerging as the avant-garde generation of natural, sustainable, and biodegradable materials for a wide range of applications. They are constituted of a self-growing and interconnected fibrous network of elongated cells, and their chemical and physical properties can be adjusted depending on the conditions of growth and the substrate they are fed upon. So far, only extracts and derivatives from mycelia have been evaluated and tested for biomedical applications. In this study, the entire fibrous structures of mycelia of the edible fungi Pleurotus ostreatus and Ganoderma lucidum are presented as self-growing bio-composites that mimic the extracellular matrix of human body tissues, ideal as tissue engineering bio-scaffolds. To this purpose, the two mycelial strains are inactivated by autoclaving after growth, and their morphology, cell wall chemical composition, and hydrodynamical and mechanical features are studied. Finally, their biocompatibility and direct interaction with primary human dermal fibroblasts are investigated. The findings demonstrate the potentiality of mycelia as all-natural and low-cost bio-scaffolds, alternative to the tissue engineering systems currently in place.
Collapse
Affiliation(s)
- Maria Elena Antinori
- Smart Materials, Fondazione Istituto Italiano Di Tecnologia, Via Morego 30, 16163, Genova, Italy
- DIBRIS, University of Genoa, Genoa, Italy
| | - Marco Contardi
- Smart Materials, Fondazione Istituto Italiano Di Tecnologia, Via Morego 30, 16163, Genova, Italy
| | - Giulia Suarato
- Smart Materials, Fondazione Istituto Italiano Di Tecnologia, Via Morego 30, 16163, Genova, Italy
- Translational Pharmacology, Fondazione Istituto Italiano Di Tecnologia, Via Morego 30, 16163, Genova, Italy
| | - Andrea Armirotti
- Analytical Chemistry Lab, Fondazione Istituto Italiano Di Tecnologia, Via Morego 30, 16163, Genova, Italy
| | - Rosalia Bertorelli
- Translational Pharmacology, Fondazione Istituto Italiano Di Tecnologia, Via Morego 30, 16163, Genova, Italy
| | - Giorgio Mancini
- Smart Materials, Fondazione Istituto Italiano Di Tecnologia, Via Morego 30, 16163, Genova, Italy
| | - Doriana Debellis
- Electron Microscopy Facility, Fondazione Istituto Italiano Di Tecnologia, Via Morego 30, 16163, Genova, Italy
| | - Athanassia Athanassiou
- Smart Materials, Fondazione Istituto Italiano Di Tecnologia, Via Morego 30, 16163, Genova, Italy.
| |
Collapse
|
4
|
Rai SN, Chaturvedi VK, Singh P, Singh BK, Singh MP. Mucuna pruriens in Parkinson's and in some other diseases: recent advancement and future prospective. 3 Biotech 2020; 10:522. [PMID: 33194526 DOI: 10.1007/s13205-020-02532-7] [Citation(s) in RCA: 61] [Impact Index Per Article: 15.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/08/2020] [Accepted: 10/28/2020] [Indexed: 12/12/2022] Open
Abstract
Mucuna pruriens (Mp) is an annual and perennial legume which belongs to the family Fabaceae having different types of therapeutic activity. Anti-oxidative, anti-inflammatory, anti-epileptic, anti-microbial, etc. are the example of some most common activities of Mp. It is widely utilized as a potent aphrodisiac. The anti-Parkinsonian activity of Mp was explored since the nineteenth century. The neuroprotective activity of Mp was shown by several researchers. Levodopa (L-DOPA) is the important constituents responsible for the anti-Parkinsonian activity of Mp. Apart from L-DOPA, several other important bioactive components like Ursolic acid (UA) and Betulinic acid (BA) also exhibit a similar neuroprotective activity. Parkinson's disease (PD) is mainly sporadic. A very small proportion shows the genetic nature of PD. The anti-Parkinsonian activity of Mp was explored in different toxin-induced PD models as like MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine), Rotenone, Paraquat, 6-hydroxydopamine (6-OHDA) as suggested by several pieces of literature. Various parts of Mp's like seed, leaf, and stem exhibit potent neuroprotective attributes. Among different parts, seeds are widely utilized as anti-PD agents because of the higher percentage of L-DOPA. Besides anti-PD activity, Mp's neuroprotective potential was also explored in the ischemic model of stroke that also shows positive results. Recently, several clinical trials have been performed on the anti-PD activity of Mp on PD patients that show convincing results. Although, a small population-based study needs to be further validated in the broader population. Apart from anti-PD activity, Mp also shows its therapeutic activity in some other diseases like cancer, diabetes, skin infection, anemia, antihypertensive, etc. that are summarized in Table 1. In this review, we have discussed the anti-PD potential of Mp in the sporadic and genetic model along with some clinical trials that have performed on PD patients. Some other activity of Mp is also summarized in this review. There is a strong need to test the efficacy of Mp in some other neurodegenerative diseases along with PD. Following this, this review emphasizes the role of Mp in PD systematically through literature analysis available to date. [Table: see text].
Collapse
|
5
|
Pradhan P, Majhi O, Biswas A, Joshi VK, Sinha D. Enhanced accumulation of reduced glutathione by Scopoletin improves survivability of dopaminergic neurons in Parkinson's model. Cell Death Dis 2020; 11:739. [PMID: 32913179 PMCID: PMC7484898 DOI: 10.1038/s41419-020-02942-8] [Citation(s) in RCA: 23] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/16/2020] [Revised: 08/23/2020] [Accepted: 08/27/2020] [Indexed: 12/18/2022]
Abstract
Parkinson’s disease (PD) is a neuromotor disorder, primarily manifested by motor anomalies due to progressive loss of dopaminergic neurons. Although alterations in genetic factors have been linked with its etiology, exponential accumulation of environmental entities such as reactive oxygen species (ROS) initiate a cyclic chain reaction resulting in accumulation of cellular inclusions, dysfunctional mitochondria, and overwhelming of antioxidant machinery, thus accelerating disease pathogenesis. Involvement of oxidative stress in PD is further substantiated through ROS induced Parkinsonian models and elevated oxidative markers in clinical PD samples; thereby, making modulation of neuronal oxidative load as one of the major approaches in management of PD. Here we have found a potent antioxidant moiety Scopoletin (Sp), a common derivative in most of the nootropic herbs, with robust neuroprotective ability. Sp increased cellular resistance to ROS through efficient recycling of GSH to prevent oxidative damage. The Sp treated cells showed higher loads of reduced glutathione making them resistant to perturbation of antioxidant machinery or neurotoxin MPP+. Sp could restore the redox balance, mitochondrial function, and prevented oxidative damage, leading to recovery of dopaminergic neural networks and motion abilities in Drosophila genetic model of PD. Our data also suggest that Sp, in combination increases the therapeutic potency of L-DOPA by mitigating its chronic toxicity. Together, we highlight the possible ability of Sp in preventing oxidative stress mediated loss of dopaminergic neurons and at the same time enhance the efficacy of dopamine recharging regimens.
Collapse
Affiliation(s)
- Priyadarshika Pradhan
- Department of Zoology, Institute of Science, Banaras Hindu University, Varanasi, 221005, India
| | - Olivia Majhi
- Department of Zoology, Institute of Science, Banaras Hindu University, Varanasi, 221005, India
| | - Abhijit Biswas
- Department of Zoology, Institute of Science, Banaras Hindu University, Varanasi, 221005, India
| | - Vinod Kumar Joshi
- Department of Dravyaguna, Institute of Medical Sciences, Banaras Hindu University, Varanasi, 221005, India
| | - Devanjan Sinha
- Department of Zoology, Institute of Science, Banaras Hindu University, Varanasi, 221005, India.
| |
Collapse
|
6
|
Baroli B, Loi E, Solari P, Kasture A, Moi L, Muroni P, Kasture S, Setzu MD, Liscia A, Zavattari P. Evaluation of oxidative stress mechanisms and the effects of phytotherapic extracts on Parkinson's disease Drosophila PINK1B9 model. FASEB J 2019; 33:11028-11034. [PMID: 31291788 DOI: 10.1096/fj.201901010] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Abstract
Oxidative stress is commonly observed in both idiopathic and genetic cases of Parkinson's disease (PD). It plays an important role in the degeneration of dopaminergic neurons, and it has been associated with altered telomere length (TL). There is currently no cure for PD, and extracts of antioxidative plant, such as Mucuna pruriens and Withania somnifera, are commonly used in Ayurveda to treat patients with PD. In this study, we evaluated 2 enzymatic markers of oxidative stress, glutathione (GSH) system and superoxide dismutase (SOD), and TL in a Drosophila melanogaster model for PD [phosphatase and tensin homolog-induced putative kinase 1 (PINK1)B9]. This evaluation was also performed after treatment with the phytoextracts. PINK1B9 mutants showed a decrease in GSH amount and SOD activity and unexpected longer telomeres compared with wild-type flies. M. pruriens treatment seemed to have a beneficial effect on the oxidative stress conditions. On the other hand, W. somnifera treatment did not show any improvements in the studied oxidative stress mechanisms and even seemed to favor the selection of flies with longer telomeres. In summary, our study suggests the importance of testing antioxidant phytoextracts in a PINK1B9 model to identify beneficial effects for PD.-Baroli, B., Loi, E., Solari, P., Kasture, A., Moi, L., Muroni, P., Kasture, S., Setzu, M. D., Liscia, A., Zavattari, P. Evaluation of oxidative stress mechanisms and the effects of phytotherapic extracts on Parkinson's disease Drosophila PINK1B9 model.
Collapse
Affiliation(s)
- Biancamaria Baroli
- Department of Life and Environmental Sciences, University of Cagliari, Cagliari, Italy
| | - Eleonora Loi
- Department of Biomedical Sciences, University of Cagliari, Cagliari, Italy
| | - Paolo Solari
- Department of Biomedical Sciences, University of Cagliari, Cagliari, Italy
| | - Ameya Kasture
- Department of Neurobiology, University of Vienna, Vienna, Austria
| | - Loredana Moi
- Department of Biomedical Sciences, University of Cagliari, Cagliari, Italy
| | - Patrizia Muroni
- Department of Biomedical Sciences, University of Cagliari, Cagliari, Italy
| | | | | | - Anna Liscia
- Department of Biomedical Sciences, University of Cagliari, Cagliari, Italy
| | - Patrizia Zavattari
- Department of Biomedical Sciences, University of Cagliari, Cagliari, Italy
| |
Collapse
|